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Abstract: Polylactide (PLA) electrospun fibers have been reported as a scaffold for bone tissue 
engineering application, however, the great hydrophobicity limits its broad application. In this 
study, the hybrid amphiphilic poly(ethylene glycol) (PEG)/hydrophobic PLA fibrous scaffolds 
exhibited improved morphology with regular and continuous fibers compared to corresponding 
blank PLA fiber mats. The prepared PEG/PLA fibrous scaffolds favored mesenchymal stem 
cell (MSC) attachment and proliferation by providing an interconnected porous extracellular 
  environment. Meanwhile, MSCs can penetrate into the fibrous scaffold through the interstitial 
pores and integrate well with the surrounding fibers, which is very important for favorable appli-
cation in tissue engineering. More importantly, the electrospun hybrid PEG/PLA fibrous scaffolds 
can enhance MSCs to differentiate into bone-associated cells by comprehensively evaluating the 
representative markers of the osteogenic procedure with messenger ribonucleic acid quantitation 
and protein analysis. MSCs on the PEG/PLA fibrous scaffolds presented better differentiation 
potential with higher messenger ribonucleic acid expression of the earliest osteogenic marker 
Cbfa-1 and mid-stage osteogenic marker Col I. The significantly higher alkaline phosphatase 
activity of the PEG/PLA fibrous scaffolds indicated that these can enhance the differentiation 
of MSCs into osteoblast-like cells. Furthermore, the higher messenger ribonucleic acid level 
of the late osteogenic differentiation markers OCN (osteocalcin) and OPN (osteopontin), 
accompanied by the positive Alizarin red S staining, showed better maturation of osteogenic 
induction on the PEG/PLA fibrous scaffolds at the mineralization stage of differentiation. After 
transplantation into the thigh muscle pouches of rats, and evaluating the inflammatory cells 
surrounding the scaffolds and the physiological characteristics of the surrounding tissues, the 
PEG/PLA scaffolds presented good   biocompatibility. Based on the good cellular response and 
excellent osteogenic potential in vitro, as well as the biocompatibility with the surrounding 
tissues in vivo, the electrospun PEG/PLA fibrous scaffolds could be one of the most promising 
candidates in bone tissue engineering.
Keywords: electrospinning, fibrous scaffolds, poly(ethylene glycol)/polylactide, mesenchymal 
stem cells, bone tissue engineering
Introduction
Bone defects resulted from trauma, abnormalities, infection, or tumor resection have 
presented a severe challenge for the regeneration of cartilage, bone, and teeth in the 
tissue regeneration field. As the traditional treatments for bone lesions, autologous bone 
grafts are restricted because of donor site morbidity and potential secondary wounds, 
while allogeneic bone grafts are limited because of the risk of potential transmission 
of pathogens.1 As a consequence, various bone substitutes with similar structure and 
function to autologous bones have been proposed. As temporary templates for cell International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Dovepress
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seeding, migration, proliferation, and differentiation prior 
to the regeneration of natural extracellular matrix (ECM) 
or biological functional tissue,2,3 biomaterial scaffolds for 
bone tissue engineering applications require consideration of 
proper toughness for cell adhesion, porous three-dimensional 
structure for cell migration and new bone tissue ingrowth, 
as well as good osteoconductivity to promote bone repair.4,5 
In recent years, electrospun fibers as bone scaffolds have 
received great attention for the following reasons: (1) their 
morphologies are similar to the structures of natural ECM, 
(2) their intrinsic large surface area-to-volume ratios offer 
sufficient space for cell adhesion and proliferation, and 
(3) their interconnected porous structures can provide win-
dows for nutrient and metabolic waste exchange,6,7 as well 
as promote vascularization to apply nutrient and drain the 
consumed metabolites in vivo.8
The electrospinning technique was originally developed 
by Zeleny in 1914,9 and was first patented in the 1930s.10 
Electrospinning is a remarkably simple and versatile tech-
nique capable of producing microscale or nanoscale polymer 
fibers directly from a variety of polymers and composite 
materials. However, there was little interest in electrospin-
ning or electrospun fibers outside of the filter industry until 
the mid-1990s.11 As a remarkably simple and versatile 
technique, electrospinning has received great attention in a 
broad range of biomedical applications, such as sensors,12 
photovoltaic cells,13 chemically- and biologically-resistant 
clothing, carriers for drug delivery system, barriers for the 
prevention of adhesion, substrates for wound dressing, sup-
ports for biocatalysis, active components for biosensing,14 
and especially as scaffolds for tissue engineering during the 
past two decades. To be successfully applied in bone tissue 
engineering, electrospun fibers essentially need to have good 
cell responses and osteoconductivity. In fact, electrospun 
nonwoven polymer fabrics have been extensively applied as 
scaffolds for bone-like cells15–17 and mesenchymal stem cells 
(MSCs)18,19 based on the advantages of operation facility, 
easy accommodation, and interconnected porous structures. 
Furthermore, some studies have certified that electrospun 
fibers alone can be tailored to fabricate functional scaffolds 
in bone tissue engineering and enhance bone regeneration to 
a certain extent without any inflammatory reaction.11,20
During recent decades, many electrospun polymers 
have been used for bone tissue engineering, which include 
both nonbiodegradable and biodegradable polymers either 
with a synthetic or natural origin. Among them, nonbiode-
gradable electrospun polymers such as polyurethane and 
polyester urethane could interfere with tissue turnover and 
remodeling due to their slow degradation, even though they 
possessed substantial mechanical stability.21,22 Many biode-
gradable electrospun polymers have been fabricated such 
as collagen,23 chitosan,24 poly(glycolic acid),25 polylactide 
(PLA),26 poly(ε-caprolactone),27 poly(lactide-co-glycolide),28 
and polyanhydride.29 Among the biodegradable electrospun 
polymers, PLA has been used clinically in bone repair due 
to its tunable mechanical properties, and it can degrade 
gradually to natural metabolites along with the construc-
tion of new tissue and finally be replaced by the new tissue. 
However, based on their inherent hydrophobic nature, the 
resorbable biocompatible PLA scaffolds may reduce expres-
sion of phenotypic markers by adherent osteoblasts,30 and 
further influence cell attachment and proliferation due to 
the denaturation of adhesive ligands of cells,24,31 which are 
far from desirable. During recent years, some efforts have 
been undertaken to graft hydrophilic moieties in order to 
make PLA scaffolds more conducive for cell attachment, 
proliferation, and differentiation. As reported, the blend-
ing of amphiphilic polyether poly(ethylene glycol) (PEG) 
to PLA can modulate the inherent hydrophilicity property, 
crystallinity, tensile strength, and degradation behaviors.32 
Accordingly, electrospun hybrid scaffolds were prepared in 
this study by blending PLA with amphiphilic PEG as filler 
to tailor the scaffolds’ hydrophilic properties, and to improve 
cell responses such as cell attachment, proliferation, and 
osteoblastic differentiation.33,34
MSCs isolated from bone marrow are multipotent cells that 
can be induced to differentiate into a variety of   mesenchymal 
tissues including bone, cartilage, tendon, fat, and muscle both 
in vitro and in vivo.1 MSCs have been widely applied in tissue 
engineering because they are easy to get and manipulate, can 
be easily differentiated, are biocompatible almost without 
immune response or tumorigenesis, and especially because 
they pose no ethical or legal problems.35 Therefore, MSCs are 
well suited to act as seed cells for successful tissue renewal 
and replacement of damaged and diseased musculoskeletal 
tissues in bone tissue engineering.36
In this study, the uniform and continuous PEG/PLA 
fibrous scaffolds presented good cell responses and 
excellent osteogenic ability in the MSCs differentiation 
  procedure. For further application in bone repair in vivo, 
the biocompatibility of the fibrous scaffolds were specially 
examined with hematoxylin and eosin staining after being 
transplanted into the thigh muscle pouches of rats. All the 
results demonstrated that the PEG/PLA hybrid fibrous scaf-
folds showed ideal potential for broad application in bone 
tissue engineering.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Materials and methods
Materials
Semicrystalline grade PLA 4032D with approximately 2% 
of D-lactic acid monomer used in this study was supplied 
by NatureWorks LLC (Minneapolis, MN). PEG (number 
average molecular weight = 4000) was purchased from 
Sigma-Aldrich (St Louis, MO). PLA and PEG were dried in 
a vacuum oven at 110°C and 50°C for 24 hours before use, 
respectively. Dichloromethane was obtained from Kelong 
Chemical (Chengdu, China) and used as solvent. All other 
used chemical agents were of analytical reagent grade.
electrospinning process
A known amount of dried PEG and PLA (PEG/PLA = 5/95) 
were dissolved in dichloromethane with vigorous stirring for 
6 hours to form a 60 mg/mL transparent and homogeneous 
solution. PEG/PLA solution was electrospun at a high volt-
age of 18 kV driven by a high voltage power supply (High 
Voltage Technology Institute, Beijing, China) under 60% 
humidity at room temperature. The obtained solution was 
directly transferred into a 20 mL plastic syringe (Becton, 
Dickinson and Company, East Rutherford, NJ) at the feed-
ing rate of 6 mL/hour, which was set by a syringe pump 
(Smiths Medical Instrument Company, Zhejiang, China). 
The spinneret was capped with a blunt-end needle with an 
inner diameter of 0.5 mm, and the distance between the spin-
neret and the grounded aluminum foil collector was 12 cm. 
Pure PLA fibers were also prepared in the same processing 
conditions for comparison. All obtained electrospun fibrous 
scaffolds were dried under vacuum for 48 hours to eliminate 
any potential residual solvents and kept in a desiccator for 
further characterization and application.
Morphological characterization
In order to investigate the surface morphologies and the micro-
structure of the electrospun PEG/PLA hybrid fibrous scaffold, 
scanning electron microscopy (SEM) analysis was conducted 
(JSM-5900 Low Vacuum SEM; JEOL, Tokyo, Japan). After 
being seeded with cells for predetermined time, the fibrous scaf-
folds were fixed using 2.5% glutaraldehyde overnight at 4°C. 
Subsequently, they were dehydrated in ethanol with a series of 
concentrations (30%, 50%, 70%, 80%, 90%, 95%, and 100%) 
and dried in vacuum. All the samples were sputter-coated with 
a thin layer of gold using an SBC-12 Ion Sputtering Coater 
(KYKY Technology Development Ltd,   Beijing, China) and 
observed at 20 kV accelerating voltage. The average diameters 
of the electrospun fibers were obtained by analyzing at least 
40 measurements randomly per specimen.
Isolation and culture of rat bone  
marrow Mscs
The neonate Sprague Dawley rats (3 days old) were purchased 
from the Laboratory Animal Center of Sichuan University 
(Chengdu, China). The experiments were performed based 
on the Principles of Laboratory Animal Care formulated by 
the National Society for Medical Research and the Guide 
for the Care and Use of Laboratory Animals,37 and all pro-
tocols were operated according to the Animal Care and Use 
Committee of West China Hospital, Sichuan University. The 
fresh femur were harvested aseptically from the neonate 
rats which were anesthetized and sterilized with alcohol 
and   povidine.38 The bone marrow was flushed out with 
Dulbecco’s modified Eagle’s medium (Life Technologies, 
Carlsbad, CA) supplemented with 10% fetal bovine serum 
(Thermo Fisher Scientific, Waltham, MA), 100 unit/mL 
penicillin (Life   Technologies) and 100 µg/mL streptomycin 
(Life Technologies) using a 1 mL syringe. The obtained solu-
tion was cultured in a 75 cm2 tissue culture flask at 37°C, 
5% carbon dioxide. Culture medium was changed every 
3–4 days, and MSCs approached confluency after about 1 
week. Rat bone MSCs were trypsinized briefly with 0.25% 
trypsin and subcultured at 1:3 ratio. In this study, passage-3 
MSCs were used for research on cell adhesion, proliferation, 
and   differentiation. For osteogenic differentiation, MSCs 
were cultured in osteogenic culture medium, which was 
Dulbecco’s modified Eagle’s medium supplemented with 
10% fetal bovine serum, 100 unit/mL penicillin, 100 µg/mL 
streptomycin, 50 g/mL ascorbic acid, 10 mM glycerophos-
phate, and 10−8 M dexamethasone (Sigma-Aldrich).
Cell viability evaluation and fluorescence 
microscopy observation
The viability of MSCs cultured on the PEG/PLA hybrid fibrous 
scaffold was evaluated by 3-(4,5-  dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide assay. The mechanism of this 
assay is that metabolically active cells react with a tetrazo-
lium salt to produce a soluble formazan dye. The rat bone 
MSCs were cultured on the electrospun fibrous scaffolds at 
37°C under 5% carbon dioxide for the predetermined time. 
Subsequently, 20 µL of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide stock solution (5 mg/mL) in 
phosphate buffered saline (PBS) was added to each well 
and the cells were further incubated for another 4 hours. The 
precipitated formazan was dissolved in 100 µL dimethyl 
sulfoxide, and the absorbance at 570 nm was measured with 
spectrophotometer (Spectronic™ 20D+; Thermo Fisher 
  Scientific). Experiments were repeated in triplicate.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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In order to be observed by fluorescence microscopy 
(DM IL; Leica Microsystems, Wetzlar, Germany), the 
rat bone MSCs were stained by fluorescein diacetate and 
2-(4-amidinophenyl)-6-indolecarbamidine dihydrochloride 
(Sigma-Aldrich), and cell morphology was also observed 
by optical microscopy.
In vitro Mscs differentiation study
Messenger ribonucleic acid (mrNA) extraction and 
real-time polymerase chain reaction (Pcr) analysis
The total RNA of cultured MSCs was isolated using TRIzol® 
Reagent (Life Technologies) according to the manufac-
turer’s protocol. Briefly, 1 µg total RNA was first reversely 
transcribed to complementary DNA by Moloney Murine 
Leukemia Virus Reverse Transcriptase (Life Technologies). 
Then the real-time PCR reaction was carried out in a 96-well 
format with Taq polymerase (Thermo Fisher Scientific) 
and the SYBR® Premix Ex Taq™ II (Perfect Real-Time) 
PCR kit (Takara Biotechnology, Dalian, China) on a DNA 
Engine® PTC-200 Thermal Cycler (Bio-Rad Laboratories, 
Hercules, CA). The primers of differentiation markers are 
listed in Table 1. The levels of β-actin mRNA in each sample 
were used as an internal control, relative quantities were 
analyzed by 2−∆∆Ct method. All reactions were carried out 
in triplicate and the results were analyzed by Gene Expres-
sion Analysis for iCycler iQ® Real-Time PCR Detection 
System (Bio-Rad). The products were visually analyzed on 
2% agarose gel.
Alkaline phosphatase (ALP) activity assay
MSCs were cultured in osteogenic culture medium, and their 
ALP activity was assessed on day 4, 7, 14, and 21. The cul-
tured cell layer was rinsed twice with PBS 1× and lysed by 
ALP buffer (GenMed LLC, San Diego, CA). Protein content 
was estimated using the Bradford assay method (GenMed). 
The hydrolysis of a colorless organic phosphate ester p-nitro-
phenyl phosphate to the yellow p-nitrophenol was catalyzed 
by ALP. The absorbance of the yellow product was measured 
at 405 nm using a spectrophotometer   (Spectronic™ 20D+; 
Thermo Fisher Scientific). ALP activity was also visually 
stained using reagent B as AP-Red concentrated solution 
and reagent A as AP-Red accentuator according to the manu-
facturer’s protocol (ZSGB-BIO, Inc, Beijing, China). The 
  cultured cells were rinsed twice with PBS 1× and immersed in 
the alkaline-dye mixture for 10 minutes at room   temperature. 
Subsequently, the dyed cells were rinsed in deionized water 
and investigated microscopically.
Alizarin red s (Ars) staining and quantitation
ARS staining was used to quantify the mineralization of 
MSCs grown on the PEG/PLA hybrid fibrous scaffold with 
a glass coverslip as a fiber-supporting substrate, and cells 
on the glass coverslip alone were included as a control. The 
cell-scaffold construct was washed twice with PBS 1× and 
fixed with 10% formaldehyde for 10 minutes. After being 
washed with PBS 1×, the constructs were incubated with 
the staining solution (1% ARS in 2% ethanol) for 5 minutes. 
Subsequently, the staining solution was removed and the 
constructs were washed three times with distilled water to 
get rid of excessive color. To quantify the mineralization, the 
constructs were desorbed using 10% cetylpyridinium chlo-
ride (Sigma-Aldrich) for 1 hour. The solution was collected 
and the absorbance at 570 nm was measured with the spec-
trophotometer, which was performed in triplicate wells.
histological analysis in vivo
To further evaluate the tissue responses to the implanted 
scaffold in vivo, the PEG/PLA fibrous scaffold was trans-
planted into the thigh muscle pouches of rats. All animal care 
and experimental procedures were conducted according to 
institutional Animal Care and Use guidelines. Briefly, the 
Sprague Dawley rats (4 weeks old, 200 ± 20 g) were first 
anesthetized with intraperitoneal injection of chloral hydrate 
(0.3 mL/100 g) until effectively anesthetized. Subsequently, 
the PEG/PLA fibrous scaffold was transplanted into the 
thigh muscle pouches. Three rats were randomly sacrificed 
Table 1 Nucleotide primers used for reverse transcription polymerase chain reaction
Gene Primer sequences Annealing Product size (bp) GenBank accession number
Cbfa-1 F 5′–ATgcgTATTcccgTAgATc 56°c 487 NM_053470.1
r 5′–gTAgcTcggcAgAgTAgTTc
Col I F 5′–TggATggcTgcAcgAgT 56°c 177 NM_053304.1
r 5′–TTgggATggAgggAgTTTA
OCN F 5′–AgggcAgTAAggTggTgAA 56°c 143 NM_013414.1
r 5′–gccAATgTggTccgcTA
OPN F 5′–cAgcAggAcTgAAggAgc 55°c 148 NM_012881.2
r 5′–ggAgAcAggAggcAAggInternational Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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at predetermined time of 2 weeks and 4 weeks, and the 
excised implant and surrounding muscle were fixed in 10% 
formalin for histological analysis. The fixed specimens were 
serially dehydrated in a graded series of ethanol washes 
and embedded in paraffin, then eight micron-thick sections 
were cut and stained according to standard protocols for 
hematoxylin and eosin staining. All hematoxylin and eosin 
results were analyzed with a digital image analysis system 
(Eclipse E600 microscope with DXM 1200 digital camera; 
Nikon Corporation, Tokyo, Japan).
statistics
Statistical analysis was performed using the GraphPad Prism 
(v 5.0; GraphPad Software, Inc, La Jolla, CA) and the sta-
tistical significance of the difference between groups was 
found by one-way analysis of variance. Quantitative data 
were represented as mean ± standard deviation and statistical 
significance was set at P , 0.05.
Results
Morphology analysis of the electrospun 
PEG/PLA fibrous scaffolds by SEM
The morphology of the electrospun fibrous scaffolds was 
observed by SEM (Figure 1). Under optimized electrospin-
ning conditions (eg, solvent, solution concentration), PEG/
PLA (PEG/PLA = 5/95, optimized by the authors, data not 
shown) hybrid solution was electrospun to form smooth uni-
form fibers (Figure 1C and D). The average diameter of the 
PEG/PLA electrospun fibers obtained was 2.01 ± 0.32 µm, 
which was one to two orders of magnitude smaller than 
mammalian cells, and included the range of feature sizes 
known to facilitate contact guidance.39 For pristine PLA 
fiber mats as presented in Figure 1A and B, the diameter of 
the electrospun fibers had a broad distribution ranging from 
200 nm to 5 µm, some with spindle-shaped structures. The 
irregular and discontinuous fibers may be due to the intrinsic 
properties of PLA solution such as hydrophobicity, viscosity, 
and surface tension.28,29 The spun PLA/PEG fibers were long 
and continuous, which may be attributed to the reduction of 
solution viscosity caused by the use of the low molecular 
weight PEG as lubricant.
cell behavior of Mscs on the Peg/PLA 
fibrous scaffolds
Cell morphology and spreading, as well as cell interaction 
with the electrospun fibrous scaffolds were studied by SEM 
(Figure 2). On the day following cell seeding (Figure 2A 
and B), MSCs had already expanded on the surface of the 
electrospun fibrous scaffolds, and the anchoring ligands 
of the cells had stretched out to elongate along individual 
fibers thinner than themselves. Meanwhile, the seeded cells 
were thin and narrow in shape, and adhered to a relatively 
small area of the scaffold.40 Subsequently, MSCs started to 
migrate through the pores and integrated well with the sur-
rounding fibers on day 3 (Figure 2C and D). Moreover, it 
A
20 kV ×500 50 µm
20 kV ×500 50 µm 20 kV ×1,000 10 µm
20 kV ×1,000 10 µm
B
CD
Figure 1 scanning electron microscope images of the electrospun pure polylactide 
(PLA) and poly(ethylene glycol) (Peg)/PLA hybrid membrane. (A) Pure PLA, 500×; 
(B) pure PLA, 1000×; (C) Peg/PLA, 500×; and (D) Peg/PLA, 1000×. 
A
20 kV ×500 50 µm
20 kV ×500 50 µm 20 kV ×1,000 10 µm
20 kV ×500 50 µm 20 kV ×1,000 10 µm
20 kV ×1,000 10 µm
B
C D
EF
Figure 2 scanning electron microscope observations of rat bone mesenchymal 
stem cell adhesion and growth on the electrospun poly(ethylene glycol)/polylactide 
hybrid membranes for 1 day (A, B), 3 days (C, D), and 5 days (E, F) at different 
magnification (A, C, E: 500×; B, D, F: 1000×). International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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became extremely difficult to determine the exact boundary 
of a single cell since the cells grew massively and formed a 
continuous layer. MSCs on the fibrous scaffolds expanded 
even more and almost reached confluence after 5 days in 
culture (Figure 2E and F). Interestingly, MSCs began to pen-
etrate into the fibrous scaffold through the interstitial pores 
between the fibers and grow underneath the fiber network 
from day 3. The penetration of cells into the fibrous scaffolds 
was significantly meaningful for the cytocompatibility evalu-
ation and very important for favorable application in tissue 
engineering. This is because the functional tissue can only 
be regenerated when cells migrate through the scaffolds, but 
not when they just stay on the scaffold surface.41
Cell viability and metabolic activity of MSCs cultured 
on the PEG/PLA electrospun fibrous scaffolds showed a 
statistically significant increase compared with those on the 
tissue culture plate 1 day and 3 days after seeding (Figure 3). 
However, the cells on the scaffolds proliferated slightly up 
to day 5 when the MSCs began to differentiate, which is in 
accordance with osteoblast proliferation and differentiation 
having conflicting properties.42 The higher cell viability for 
the PEG/PLA electrospun fibrous scaffolds demonstrates that 
the electrospinning scaffolds can accelerate initial attach-
ment of the cells and promote cells to penetration into fiber 
  substrates, which is important for the application of biomate-
rial scaffolds.4,33 In order to further confirm cytocompatibility 
of the PEG/PLA electrospun fibrous scaffolds, fluorescent 
microscopic images of MSCs grown on the scaffolds were 
taken. As shown in Figure 4, the cells were observed to adhere 
and spread actively with a physiological adherence pattern on 
both the tissue culture plate and the fibrous scaffolds.
Mscs osteogenic development  
on the PEG/PLA fibrous scaffolds
In addition to attachment and proliferation, the ability to 
support cultured cell differentiation is another actual appli-
cability of the scaffold. By analyzing the genes of different 
clusters and their expression profiles, there were three main 
phases of osteogenic development procedure as reported: 
proliferation, matrix maturation, and mineralization,43 as 
shown in Figure 5.
Gene expression profile during osteogenic procedure
To confirm the osteogenic differentiation of MSCs on the 
PEG/PLA fibrous scaffolds, induction of osteoblast-specific 
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Figure 3 Mesenchymal stem cells viability and metabolic activity evaluation on the 
poly(ethylene glycol)/polylactide hybrid membranes, with the tissue culture plate as 
the control. 
Note: error bars represent standard deviation; n = 3. 
Abbreviations: Peg/PLA, poly(ethylene glycol)/polylactide; OD, optical density.
Figure 4 Fluorescence micrographs show the cytocompatibility of the poly(ethylene 
glycol)/polylactide  electrospun  fibrous  scaffolds  with  mesenchymal  stem  cells 
(C, D). Mesenchymal stem cells cultured on the tissue culture plate were the control 
(A, B). The cells were stained with fluorescein diacetate in green color (A, C) and 
2-(4-amidinophenyl)-6-indolecarbamidine dihydrochloride for cell nuclei in blue (B, D). 
Mesenchymal stem cells on the poly(ethylene glycol)/polylactide electrospun fibrous 
scaffolds under white light were also included at different magnification (E, F).
Note: scale bar = 100 μm. 
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Figure 5 graphical summary of the three phases and time schedule of osteogenic 
induction: proliferation, matrix maturation, and mineralization. International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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genes was examined by real-time polymerase chain reaction 
(PCR) (Figure 6). As the earliest osteogenic marker, the 
transcriptional factor Cbfa-1 drove the pluripotent MSCs 
to preosteoblasts by initiating the expression of many bone 
specific genes.44 Col I comprised 90%–95% of the organic 
material of mineralized ECM and served as a template upon 
which mineral deposited, which was well known as one 
of the mid-stage osteogenic markers.45 The expression of 
Cbfa-1 and Col I was upregulated during the whole period of 
  differentiation; maximum expression was reached on day 21. 
Furthermore, the expression of Cbfa-1 and Col I of MSCs 
on the scaffolds was significantly higher than those on the 
glass coverslip throughout differentiation. The maturation of 
  differentiation was accomplished with the secretion of the late 
osteogenic differentiation markers OCN (osteocalcin) and 
OPN (osteopontin). After 14 days of osteogenic induction, 
the secreted OCN and OPN on the scaffolds showed much 
higher expression compared with the control. By evaluating 
the expression of the osteoblast phenotypic markers, MSCs 
cultured on the PEG/PLA fibrous scaffolds presented better 
osteogenic differentiation ability.
ALP activity analysis
As a well-known marker of the osteogenic phenotype, ALP is a 
glycoprotein on the cell membrane that catalyzes the hydrolysis 
of phosphate esters at an alkaline pH and plays an important 
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Figure 6 Gene expression profile of rat bone mesenchymal stem cells in osteogenic cultures. (A) Agarose gel electrophoresis result of the real-time polymerase chain 
reaction product shows the effects of the culture scaffold on gene expression on day 7, 14, and 21. (B) Quantitative analysis for Col I, Cbfa-1, OCN, and OPN expression 
was performed by gene expression Analysis for icycler iQ® real-Time Pcr Detection system (Bio-rad Laboratories, hercules, cA); relative gene expression levels were 
normalized by the housekeeping gene, β-actin. 
Note: *Represents statistically significant difference (P , 0.05), n = 3.
Abbreviation: Peg/PLA, poly(ethylene glycol)/polylactide.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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role in bone matrix mineralization process.46 In this study, 
ALP activity was visualized by ALP staining (Figure 7B and 
C) on day 14 and evaluated quantitatively in terms of µmol of 
p-nitrophenyl phosphate production per mg of protein per hour 
(Figure 7A) on day 4, 7, 14, and 21. ALP expression is known 
to peak after the end of the proliferative stage and before matrix 
maturation during osteoblastic differentiation.47 As presented in 
Figure 7A, ALP activity of MSCs cultured both on glass cov-
erslip and fibrous scaffolds presented an ongoing increase with 
culture time up to 14 days and then a decrease on day 21, which 
suggested that osteodifferentiation was occurring. Additionally, 
ALP activity was significantly higher for the PEG/PLA fibrous 
scaffolds than the control from day 7, which indicated that the 
presence of the bone-like matrix enhanced differentiation from 
MSCs to osteoblast-like cells.
ARS staining and mineralization quantification
The ARS dye binds to calcium salts selectively and is widely 
used for calcium mineral histochemistry. Figure 8A and B 
present the images of ARS staining of MSCs cultured on 
glass coverslip and PEG/PLA fibrous scaffolds on day 21 in 
osteogenic culture medium. The red stains (bone nodules) 
were ARS–calcium chelating products.48 As shown in 
  Figure 8B, the cells cultured on PEG/PLA fibrous scaffolds 
clearly showed matrix mineralization with more intense ARS 
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evaluation on day 4, 7, 14, and 21. Alkaline phosphatase staining was also performed on 
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Figure 8 Analysis of the mineral deposition in osteogenic mesenchymal stem cells 
on day 21 by Alizarin red s staining. Photographs of the Alizarin red s staining 
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Note: *Represents statistically significant difference (P , 0.05), n = 3.
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staining than the control. To quantify mineralization, con-
structs were desorbed using 10% cetylpyridinium chloride 
for 1 hour, and the absorbance of the solution was measured 
at 570 nm (n = 3). The results of the absorbance analysis 
quantitatively confirmed the higher calcium deposition of the 
PEG/PLA fibrous scaffolds (Figure 8C, P , 0.05).
On the whole, the PEG/PLA fibrous scaffolds presented 
good cellular compatibility and excellent osteogenic potential 
in vitro. Therefore, they could be one of the most promising 
candidates for potential application in tissue engineering.
histologic analysis of tissue response  
to the PEG/PLA fibrous scaffolds
The PEG/PLA fibrous scaffold was transplanted into the 
thigh muscle pouches of rats, and the histologic results were 
analyzed to evaluate the tissue responses in vivo. The host 
response was determined by measuring the inflammatory 
cells, ie, macrophage, polymorphonuclear leukocyte, lym-
phocyte, plasma cell, and giant cell. As depicted in   Figure 9A, 
an acute inflammation reaction occurred at week 2, and the 
inflammatory cells infiltrated into the PEG/PLA fibrous 
scaffold (3815 ± 317/mm2). However, the inflammation 
reaction attenuated dramatically and the number reduced 
to 201 ± 84/mm2 at 4 weeks (Figure 9B).5   Meanwhile, the 
surrounding muscle maintained its physiological charac-
teristics the whole time, as confirmed by both macroscopic 
observation (data not shown) and histologic analysis International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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(Figure 9C and D). In general, the PEG/PLA fibrous scaffold 
presented good biocompatibility in vivo.
Discussion
When used as bone tissue engineering scaffolds, electrospun 
fibers offer a range of attractive features such as large surface 
area-to-volume ratios, interconnected porous structures, ease 
of construction into different shapes, and similar structures 
to natural ECM. The advantages mentioned above made 
the electrospun fibers ideal for cell adhesion and prolifera-
tion as well as for nutrient and metabolic waste exchange. 
  Meanwhile, bone marrow MSCs are multipotent cells that 
have been considered as ideal seed cells in the bone repair.49 
Therefore, the aim in the present study was to evaluate the cell 
response of obtained PEG/PLA electrospun hybrid scaffolds 
to MSCs, and the osteogenic development behavior of MSCs 
cultured on the PEG/PLA electrospun fibrous scaffold in vitro. 
Surrounding tissue response to the fibrous scaffolds in vivo 
was also evaluated by transplanting the PEG/PLA electrospun 
hybrid scaffold into the thigh muscle pouches of rats.
As shown by SEM, the average diameter of the uniform 
and continuous hybrid PEG/PLA fibrous scaffolds was one 
to two orders of magnitude smaller than mammalian cells, 
which included the range of feature sizes to facilitate con-
tact guidance.33 The diameter of the pure PLA electrospun 
fibers had a broad distribution ranging from 200 nm to 5 µm, 
some with spindle-shaped structures. It was presumed that 
hybrid PEG/PLA fibrous scaffolds would present good cell 
response and facilitate osteoblastic differentiation.
To validate the cell response of PEG/PLA fibrous scaf-
folds, the behavior of MSCs cultured on the scaffolds, 
including the cell morphology and cell interaction with 
the electrospun fibrous scaffolds by SEM, cell viability, 
and metabolic activity by 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide accompanied with the 
fluorescent microscopic images, were evaluated. MSC 
behavior confirmed the presumption that MSCs interacted 
and integrated well with surrounding fibers. Moreover, 
MSCs attached and proliferated better on the scaffolds 
than on the glass coverslip. As reported, the cells gradu-
ally penetrated into the fibrous structures composed of 
large diameter fibers due to the large pore area of the 
fibrous structures, but failed to penetrate into the fibrous 
structures composed of small diameter fibers.27 As the 
interstitial pore sizes of obtained PEG/PLA fibrous scaf-
folds were larger than 10 µm, it was possible for MSCs 
to fully penetrate into the fibrous scaffolds through these 
pores. MSCs on the scaffolds formed a continuous layer 
and even migrated through the pores to grow underneath 
the fiber network, which is significant for favorable appli-
cation in tissue engineering as the functional tissue would 
be regenerated through the scaffolds and not just on the 
scaffold surface.
In addition to attachment and proliferation, the osteoin-
ductive capacity of a scaffold to support differentiation 
of cultured cells is another important aspect suggesting 
actual applicability of the scaffold. Of the several kinds of 
osteogenic cells, bone marrow MSCs seem to be the opti-
mal seeding cells for bone tissue engineering owing to the 
advantages mentioned above. As briefly depicted in Figure 5, 
there were three main phases of osteogenic development: 
proliferation, matrix maturation, and mineralization. As 
reported, the blending of PEG to PLA can modulate the 
hydrophilicity property and significantly enhance osteo-
blastic differentiation.33,34 Representative markers of the 
osteogenic procedure were comprehensively analyzed by 
mRNA quantitation and protein analysis (Figures 6–8). As 
the earliest osteogenic marker, mRNA level of Cbfa-1 was 
upregulated during the whole differentiation period and 
reached maximum expression on day 21. The transcriptional 
factor Cbfa-1 can drive the pluripotent MSCs to preosteo-
blasts by initiating the expression of many bone specific 
genes, so the higher expression of Cbfa-1 for MSCs on the 
PEG/PLA fibrous scaffolds presented better differentiation 
potential. The well-known mid-stage osteogenic markers 
were Col I and ALP. The higher Col I mRNA level provided 
a favorable template for the mineral deposition for the reason 
Figure 9 histologic analysis of tissue response to poly(ethylene glycol)/polylactide 
fibrous scaffolds. There was a dense accumulation of inflammatory cells presented 
around  the  poly(ethylene  glycol)/polylactide  fibrous  scaffolds  at  2  weeks  (A)  but 
attenuated  at  week  4  (B).  Meanwhile,  the  surrounding  muscle  presented  good 
physiological characteristics both at 2 weeks (C) and 4 weeks (D).
Note: scale bar = 50 μm. International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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that the Col I comprised 90%–95% of the organic material 
of mineralized ECM. The bone-forming potential of MSCs 
was further analyzed by evaluating the expression of ALP 
activity, since ALP is regarded to be an important phenotype 
of bone-forming cells. Of particular note, ALP activity of 
MSCs at all evaluation times was significantly higher on the 
PEG/PLA fibrous scaffolds than on the pure glass coverslip 
(Figure 7). At the mineralization stage of differentiation, the 
maturation of the osteogenic induction was confirmed by the 
high expression of the late osteogenic differentiation mark-
ers OCN and OPN accompanied with positive ARS staining 
 ( Figure 8). In accordance with previous results, the expression 
of the late osteogenic differentiation markers confirmed the 
presumption that the PEG/PLA fibrous scaffolds is better at 
encouraging cells to differentiate into bone-associated cells 
in vitro, which will ultimately be useful as bone constructs 
in bone tissue engineering.
Based on the good cellular compatibility and excellent 
osteogenic potential, an experiment on surrounding tissue 
response to the PEG/PLA fibrous scaffolds in vivo was 
briefly performed. Acute inflammation reaction presented at 
2 weeks, but attenuated at week 4 without unfavorable influ-
ence on the ambient muscle, which indicated that the PEG/
PLA fibrous scaffolds can get along well with surrounding 
tissues in vivo.
On the whole, the obtained PEG/PLA fibrous scaffolds 
could be one of the best potential bone implant candidates in 
bone tissue engineering. However, to confirm the practical 
usefulness of this novel PEG/PLA hybrid fibrous scaffold, 
more in-depth studies on the hybridized fibers are under way, 
in particular animal tests to find clinical applications such as 
guided bone regeneration and tissue engineering matrices.
Conclusion
In this study, uniform PEG/PLA fibrous scaffolds were suc-
cessfully prepared by electrospinning and they exhibited 
improved morphology with regular and continuous fibers 
compared to corresponding pristine PLA fiber mats. The 
obtained PEG/PLA fibrous scaffolds favored MSC attach-
ment and proliferation, furthermore, MSCs penetrated into 
the fibrous scaffold through the interstitial pores which was 
meaningful for cytocompatibility evaluation. After com-
prehensively analyzing the representative markers of the 
osteogenic procedure at mRNA level and protein level in 
vitro, as well as the histologic result of the tissue responses 
in vivo, it can be concluded that the prepared PEG/PLA 
fibrous scaffolds present excellent osteogenic potential and 
prospective use for bone tissue engineering.
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